DRW Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-732
Closed -$252K 1421
2025
Q4
$252K Buy
+732
New +$247K 0.01% 784
2025
Q3
Sell
-4,000
Closed -$1.24M 1375
2025
Q2
$1.56M Buy
4,000
+3,482
+672% +$1.4M 0.04% 231
2025
Q1
$225K Buy
+518
New +$208K 0.01% 497
2024
Q2
Sell
-1,332
Closed -$704K 556
2024
Q1
$691K Buy
1,332
+710
+114% +$353K 0.02% 206
2023
Q4
$293K Buy
622
+48
+8% +$22.2K ﹤0.01% 241
2023
Q3
$250K Sell
574
-682
-54% -$309K 0.01% 283
2023
Q2
$558K Buy
1,256
+190
+18% +$87.7K 0.01% 194
2023
Q1
$490K Buy
+1,066
New +$507K 0.01% 204
2022
Q2
Sell
-1,135
Closed -$558K 274
2022
Q1
$558K Buy
1,135
+573
+102% +$262K 0.02% 164
2021
Q4
$261K Buy
+562
New +$236K 0.01% 201
2021
Q3
Sell
-775
Closed -$296K 287
2021
Q2
$296K Buy
+775
New +$296K 0.01% 229
2018
Q1
Sell
-3,600
Closed -$810K 268
2017
Q4
$810K Buy
+3,600
New +$767K 0.09% 144

Other funds holding ELV

DRW Securities's ELV Position: Q1 2026 in Review

DRW Securities sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 732 shares — an estimated $252K sold.

DRW Securities first reported a position in ELV in Q4 2017 and held it in 12 quarters. The position peaked at $1.56M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • DRW Securities reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 732 Elevance Health shares in Q1 2026, an estimated $252K.
  • DRW Securities first reported a position in Elevance Health in Q4 2017 and held it in 12 quarters.
  • DRW Securities's Elevance Health position peaked at $1.56M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.